Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection

被引:98
作者
Horton, Helen
Frank, Ian
Baydo, Ruth
Jalbert, Emilie
Penn, Justin
Wilson, Sean
McNevin, John P.
McSweyn, Matthew D.
Lee, Deborah
Huang, Yunda
De Rosa, Stephen C.
McElrath, M. Juliana
机构
[1] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[4] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA
关键词
D O I
10.4049/jimmunol.177.10.7406
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1-infected persons with HLA-B27 and -B57 alleles commonly remain healthy for decades without antiretroviral therapy. Properties of CD8(+) T cells restricted by these alleles considered to confer disease protection in these individuals are elusive but important to understand and potentially elicit by vaccination. To address this, we compared CD8(+) T cell function induced by HIV-1 immunogens and natural infection using polychromatic flow cytometry. HIV-1-specific CD8(+) T cells from all four uninfected immunized and 21 infected subjects secreted IFN-gamma and TNF-alpha. However, CD8(+) T cells induced by vaccination and primary infection, but not chronic infection, proliferated to their cognate epitopes. Notably, B27- and B57-restricted CD8(+) T cells from nonprogressors exhibited greater expansion than those restricted by other alleles. Hence, CD8(+) T cells restricted by certain protective alleles can resist replicative defects, which permits expansion and antiviral effector activities. Our findings suggest that the capacity to maintain CD8(+) T cell proliferation, regardless of MHC-restriction, may serve as an important correlate of disease protection in the event of infection following vaccination.
引用
收藏
页码:7406 / 7415
页数:10
相关论文
共 31 条
[1]   Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection [J].
Altfeld, M ;
Addo, MA ;
Rosenberg, ES ;
Hecht, FA ;
Lee, PK ;
Vogel, M ;
Yu, XG ;
Draenert, R ;
Johnston, MN ;
Strick, D ;
Allen, TA ;
Feeney, ME ;
Kahn, JO ;
Sekaly, RP ;
Levy, JA ;
Rockstroh, JK ;
Goulder, PJR ;
Walker, BD .
AIDS, 2003, 17 (18) :2581-2591
[2]   HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function [J].
Appay, V ;
Nixon, DF ;
Donahoe, SM ;
Gillespie, GMA ;
Dong, T ;
King, A ;
Ogg, GS ;
Spiegel, HML ;
Conlon, C ;
Spina, CA ;
Havlir, DV ;
Richman, DD ;
Waters, A ;
Easterbrook, P ;
McMichael, AJ ;
Rowland-Jones, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :63-75
[3]   HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells [J].
Betts, Michael R. ;
Nason, Martha C. ;
West, Sadie M. ;
De Rosa, Stephen C. ;
Migueles, Stephen A. ;
Abraham, Jonathan ;
Lederman, Michael M. ;
Benito, Jose M. ;
Goepfert, Paul A. ;
Connors, Mark ;
Roederer, Mario ;
Koup, Richard A. .
BLOOD, 2006, 107 (12) :4781-4789
[4]   Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation [J].
Betts, MR ;
Brenchley, JM ;
Price, DA ;
De Rosa, SC ;
Douek, DC ;
Roederer, M ;
Koup, RA .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 281 (1-2) :65-78
[5]  
Borroto R J, 1997, Rev Panam Salud Publica, V1, P3
[6]   Comprehensive analysis of human immunodeficiency virus type 1 (HIV71)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection [J].
Cao, JH ;
McNevin, J ;
Holte, S ;
Fink, L ;
Corey, L ;
McElrath, AJ .
JOURNAL OF VIROLOGY, 2003, 77 (12) :6867-6878
[7]  
Cao Thai M, 2003, Hematology, V8, P1, DOI 10.1080/1024533021000059465
[8]   The influence of HLA genotype on AIDS [J].
Carrington, M ;
O'Brien, SJ .
ANNUAL REVIEW OF MEDICINE, 2003, 54 :535-551
[9]  
Ehl S, 2000, EUR J IMMUNOL, V30, P883
[10]   CD8+ T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis [J].
Fiorillo, MT ;
Maragno, M ;
Butler, R ;
Dupuis, ML ;
Sorrentino, R .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) :47-53